Hadassah

Hadassah Physician Advocates Successfully for Insurance Coverage of Medicine to Save Infant

Monday, Jan 30 2017

Prof. Shimon Reif, head of the Department of Pediatrics at Hadassah Hospital Ein Kerem.

Prof. Shimon Reif, head of the Department of Pediatrics at Hadassah Hospital Ein Kerem, successfully advocated for health insurance coverage of a medicine that a two-month-old baby with a rare metabolic disease needed to survive.

The baby’s genetic condition leads to her inability to metabolize fats. As Prof. Reif recently explained on Israeli radio, orphan diseases like this rarely have cures and when they do, the costs are very high because the medicine will only be needed for a small number of patients. The cost of this enzyme therapy called Kanuma is half a million shekels a year.

Appearing in the first weeks of life, the disease, called lysosomal acid lipase deficiency, impacts all bodily systems. The child experiences digestive and liver problems and fails to grow and is expected to live only a few months without the medication.

The Jerusalem baby's two older sisters, who were born with the same disease, both died. "This baby was brought to us when she was two months old," relates Prof. Reif. "Because of the terrible family history, we immediately did genetic testing."

Although the health basket committee had discussed approval of this medicine in October, at the time, there were no cases in Israel. “We thank God for the decision,” said the baby’s father. “We hope our daughter will now be able to grow and develop."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More